Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost
NCT06449352
Eye Diseases, Glaucoma
Austin, Texas, United States
View Trial DetailsNCT Number: NCT01488032
The purpose of the study is to prove if there is any difference in the nerve fiber layer between patients with normal- and high-tension-glaucoma with similar structural optic nerve head parameters.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
It is till now not definitely clear whether normal- and high-tension glaucoma are different forms of the same disease and whether they have similar pathogenetic mechanisms. Spectral domain optical coherence tomography (SD-OCT) is supposed to objectively evaluate retinal nerve fiber layer (RNFL) thickness. The investigators propose a study to compare the RNFL in patients with normal- and high-tension-glaucoma. In order to exclude other possible differences,which could influence the results, only patients with similar structural optic nerve head damage in both groups will be compared.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 9 Months
RNFL in upper, lower, temporal and nasal segments
Technische Universität Dresden
Other
Differences in Nerve Fiber Layer Between Patients With Normal- and High-Pressure-Glaucoma With Similar Structural Optic Nerve Damage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06449352
Eye Diseases, Glaucoma
Austin, Texas, United States
View Trial DetailsNCT06266351
Eye Diseases, Glaucoma
Tucson, Arizona, United States
View Trial DetailsNCT01254149
Eye Diseases, Glaucoma
Omaha, Nebraska, United States
View Trial DetailsNCT04014933
Eye Diseases, Glaucoma
Zurich, Canton of Zurich, Switzerland
View Trial Details